Skip to main content
. 2020 Jul 10;12(7):742. doi: 10.3390/v12070742

Table 6.

MNA test results for 50× concentrated BAFASAL®.

Test Item CBPI RI [%] Cytotoxicity% MN [‰] p Value Cells with MN [‰] p Value Result
3 h (−S9)
PBS control 1.97 100 0 36 NA 32 NA NA
0.2 µg/mL MMC 1.89 92 8 52 0.0243 (*) 45 0.0366 (*) positive
0.4 µg/mL MMC 1.91 93.7 6.3 70 <0.0001 (****) 64 0.0001 (****) positive
H2O control 1.95 100 0 31 NA 28 NA NA
0.25 µL/mL BAFASAL® 50× 1.97 102.2 −2.2 32 0.9279 31 0.9243 negative
0.5 µL/mL BAFASAL® 50× 1.98 103.8 −3.8 26 0.9448 25 0.7269 negative
1 µL/mL BAFASAL® 50× 1.99 104.5 −4.5 28 0.3837 24 0.6028 negative
2 µL/mL BAFASAL® 50× 2.03 109.3 −9.3 33 0.6002 30 0.5204 negative
5 µL/mL BAFASAL® 50× 2.06 11.9 −11.9 32 0.7561 29 0.8099 negative
27 h (−S9)
PBS control 1.83 100 0 9 NA 9 NA NA
0.1 µg/mL MMC 1.78 94.9 5.1 21 0.0033 (**) 20 0.0039 (***) positive
0.2 µg/mL MMC 1.83 100.8 −0.8 26 <0.0001 (****) 24 0.0002 (***) positive
H2O control 1.82 100 0 12 NA 12 NA NA
0.25 µL/mL BAFASAL® 50× 1.85 104.4 −4.4 17 0.8846 15 0.8846 negative
0.5 µL/mL BAFASAL® 50× 1.85 104.7 −4.7 14 0.2936 13 0.5003 negative
1 µL/mL BAFASAL® 50× 1.79 96.4 3.6 14 0.6833 13 0.8924 negative
2 µL/mL BAFASAL® 50× 1.84 102.9 −2.9 16 0.6807 14 0.8896 negative
5 µL/mL BAFASAL® 50× 1.87 106 −6 12 0.3558 11 0.5889 negative
3 h (+S9)
PBS control 1.86 100 0 38 NA 35 NA NA
5 µg/mL CP 1.74 86.7 13.3 91 <0.0001 (****) 86 <0.0001 (****) positive
10 µg/mL CP 1.64 74.6 25.4 152 <0.0001 (****) 143 <0.0001 (****) positive
H2O control 1.84 100 0 39 NA 35 NA NA
0.25 µL/mL BAFASAL® 50× 1.84 99.7 0.3 40 0.9354 37 0.932 negative
0.5 µL/mL BAFASAL® 50× 1.85 101 −1 35 0.8947 32 0.7669 negative
1 µL/mL BAFASAL® 50× 1.92 109.2 −9.2 31 0.5972 29 0.7181 negative
2 µL/mL BAFASAL® 50× 1.84 99.5 0.5 40 0.259 39 0.3324 negative
5 µL/mL BAFASAL® 50× 1.92 110.1 −10.1 39 0.8891 36 0.5846 negative

Notes: Statistically significant levels: ns p > 0.05; * p ≤ 0.05; ** p ≤ 0.01; *** p ≤ 0.001; **** p < 0.0001.